Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Song, T. J. Shin, J. I. Yon, D. K. Lee, S. W. Hwang, S. Y. Hwang, J. Park, S. H. Lee, S. B. Lee, M. H. Kim, M. S. Koyanagi, A. Tizaoui, K. Kim, J. H. Smith, L.

Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Faghihi, H. Mottaghi-Dastjerdi, N. Sharifzadeh, M. Rahimi Kakavandi, N.

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Albakri, K. Abdelwahab, O. A. Gabra, M. D. Nafady, M. H. Alabdallat, Y. J. Soliman, A. Cadri, S. Hanaqtah, B. Albazee, E.

Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Rosca, E. C. Bilavu, R. Cornea, A. Simu, M.

Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Alijanzadeh, D. Soltani, A. Afra, F. Salmanpour, F. Loghman, A. H. Samieefar, N. Rezaei, N.

Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tayebi, A. H. Samimisedeh, P. Jafari Afshar, E. Ayati, A. Ghalehnovi, E. Foroutani, L. Abbasi Khoshsirat, N. Rastad, H.

Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Zhou, H. Ye, Q.

Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Yuan, Z. Shao, Z. Ma, L. Guo, R.

Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Chenchula, S. Amerneni, K. C. Ghanta, M. K. Padmavathi, R. Chandra, M. B. Adusumilli, M. B. Chavan, M. Mudda, S. Gupta, R. Lakhawat, B.

Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.

Common Characteristics of Shoulder Injury Related to Vaccine Administration (SIRVA) Following COVID-19 Vaccination: A Comprehensive Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...